AIG reports Q2 results today after a Q2 beat already landed post-market — the question now is whether the details hold up to scrutiny and whether the stock can finally close its gap to the Street's price targets.
Options positioning into the print reads as mildly cautious rather than outright bearish. The put/call ratio has climbed to 1.17, above its 20-day average of 1.09, though the move is modest — less than one standard deviation above the mean. That suggests hedging activity has picked up, but without the urgency of a genuine panic setup. The stock itself closed at $79.97, up 1.4% on the week but essentially flat on the month, lagging a peer group where EG and CB both gained on the day. AIG's year-to-date underperformance against insurers like HIG and MET remains a visible drag on sentiment.
The analyst debate has sharpened in recent weeks. The bullish case is anchored by Cantor Fitzgerald's upgrade to Overweight at $92 in early July and UBS's Buy rating with an $98 target — both pointing to stabilising P&C underwriting returns, 13% year-over-year growth in net investment income, and Convex's 25% premium CAGR. JP Morgan reinforced that direction, raising its target to $90. The sceptics have an equally concrete counterpoint: Piper Sandler downgraded to Neutral and cut to $80, citing underwriting margin pressure and a competitive landscape that limits earnings acceleration. The consensus mean of $88.55 implies meaningful upside from current levels, but the stock's inability to rally toward that figure despite positive analyst revisions tells its own story about investor conviction.
Short interest is low and falling — at 1.7% of the free float and down roughly 5.6% over the past month — and borrow conditions are entirely unthreatening, with cost to borrow near 0.27% and availability effectively uncapped. This is not a crowded short; the overhang is fundamental, not positional. The most pointed note from the recent ORTEX data is that AIG's short score of 30.9 ranks in just the 68th percentile, consistent with modest short-side interest that has been gradually unwinding as the upgrade cycle has built.
Today's print is less about the headline EPS beat — a recent note flags that already happened — and more about whether the underlying underwriting margins, Convex growth trajectory, and capital return cadence are strong enough to finally pull the stock toward a consensus that has been sitting roughly 10% above market price for most of the year.
See the live data behind this article on ORTEX.
Open AIG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
